SignatureFD’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-60
Closed -$4.07K 3185
2024
Q1
$4.07K Buy
60
+36
+150% +$2.38K ﹤0.01% 2606
2023
Q4
$1.48K Hold
24
﹤0.01% 2837
2023
Q3
$1.42K Hold
24
﹤0.01% 2863
2023
Q2
$1.43K Buy
24
+6
+33% +$357 ﹤0.01% 2891
2023
Q1
$1.05K Buy
+18
New +$1.08K ﹤0.01% 2980
2022
Q4
Sell
-150
Closed -$8K 3342
2022
Q3
$8K Hold
150
﹤0.01% 2185
2022
Q2
$10K Hold
150
﹤0.01% 2108
2022
Q1
$10K Hold
150
﹤0.01% 2156
2021
Q4
$10K Hold
150
﹤0.01% 2125
2021
Q3
$9K Hold
150
﹤0.01% 2116
2021
Q2
$9K Hold
150
﹤0.01% 2036
2021
Q1
$9K Hold
150
﹤0.01% 1895
2020
Q4
$9K Hold
150
﹤0.01% 1739
2020
Q3
$8K Hold
150
﹤0.01% 1724
2020
Q2
$8K Hold
150
﹤0.01% 1641
2020
Q1
$7K Hold
150
﹤0.01% 1584
2019
Q4
$8K Hold
150
﹤0.01% 1519
2019
Q3
$7K Hold
150
﹤0.01% 1527
2019
Q2
$8K Hold
150
﹤0.01% 1467
2019
Q1
$8K Hold
150
﹤0.01% 1477
2018
Q4
$7K Hold
150
﹤0.01% 1451
2018
Q3
$8K Hold
150
﹤0.01% 1429
2018
Q2
$8K Hold
150
﹤0.01% 1439
2018
Q1
$7K Buy
+150
New +$7.7K ﹤0.01% 1319
2016
Q4
Sell
-150
Closed -$7K 686
2016
Q3
$7K Buy
+150
New +$7.61K ﹤0.01% 1125

Other funds holding IHE

SignatureFD's IHE Position: Q2 2024 in Review

SignatureFD sold out of iShares US Pharmaceuticals ETF (IHE) in Q2 2024, closing a stake of 60 shares — an estimated $4.07K sold.

SignatureFD first reported a position in IHE in Q3 2016 and held it in 25 quarters. The position peaked at $10K in Q2 2022. 143 funds tracked by Wall St. Rank hold IHE as of Q2 2024.

  • SignatureFD reported no remaining iShares US Pharmaceuticals ETF position as of Q2 2024 after selling out during the quarter.
  • SignatureFD sold 60 iShares US Pharmaceuticals ETF shares in Q2 2024, an estimated $4.07K.
  • SignatureFD first reported a position in iShares US Pharmaceuticals ETF in Q3 2016 and held it in 25 quarters.
  • SignatureFD's iShares US Pharmaceuticals ETF position peaked at $10K in Q2 2022.
  • 143 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2024.

Based on SignatureFD's 13F filing for Q2 2024, filed 29 Jul 2024.